相关实验视频

Updated: Jul 19, 2025

Measuring Microbial Mutation Rates with the Fluctuation Assay

Measuring Microbial Mutation Rates with the Fluctuation Assay

Published on: November 28, 2019

在癌症中局部突变过程的序列依赖性和突变率

Gustav Alexander Poulsgaard^1,2, Simon Grund Sørensen^1,2, Randi Istrup Juul^1,2

¹Department of Clinical Medicine, Aarhus University, Palle Juul-Jensens Boulevard 82, 8200, Aarhus N, Denmark.

Genome medicine

|August 17, 2023

概括

癌症突变热点与特定的DNA序列背景和突变特征有关. 这项研究对这些局部突变过程进行了分类,揭示了序列偏好和突变率,以更好地理解癌症突变.

科学领域:

基因组学就是基因组学.
癌症生物学癌症生物学
生物信息学是一种生物信息学.

背景情况:

癌症突变是由复制错误和DNA损伤引起的,在序列环境和基因组区域的不同速度.
突变热点,癌症中反复发生的突变部位,表明局部化过程具有较高的突变率.
了解序列偏好对于破译癌症突变起源至关重要.

研究的目的:

将11-mer基因组序列与突变特征,单核酸变异热点和特定的基因组区域联系起来.
为了推导出突变序列动机并评估突变率.
编目局部突变过程,它们的序列偏好和突变率.

主要方法:

在整个基因组中计数11多个基因组序列.
使用PCAWG数据集的2583个泛癌整体基因组.
将11-mers与突变特征,热点和基因组区域关联起来,以获得序列动图.

主要成果:

突变热点可以识别高度可变的序列环境.
特定的突变特征 (例如,17b,62,7a,72) 在热点环境中得到了丰富,显示了定义的序列偏好.
突变速率和序列偏好可以在特定的基因组区域进一步放大,比如62签名的转录区域 (增长高达9倍).

结论:

已经建立了局部突变过程,它们的序列偏好和突变率的目录.
本目录有助于理解特定突变特征及其区域变异的病因学.
这些发现提高了对癌症突变机制的理解,并为进一步研究提供了资源.

关键词:

热点地区是热点地区.突变率的变化率是什么突变过程是突变过程.胰腺癌是一种癌症.

更多相关视频

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

相关概念视频

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Mismatch Repair

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

Mutations in Microorganisms

Mutations in Microorganisms

Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Mutations

Mutations